BMO Capital Reaffirms Their Buy Rating on AMN Healthcare Services (AMN)
BMO Capital Maintains AMN Healthcare Services(AMN.US) With Buy Rating, Maintains Target Price $71
Buy Rating on AMN Healthcare Services Amidst Mixed Performance and Positive Future Outlook
AMN Healthcare Services Analyst Ratings
Navigating 3 Analyst Ratings For AMN Healthcare Services
AMN Healthcare Services Analyst Ratings
Benchmark Co. Sticks to Their Hold Rating for AMN Healthcare Services (AMN)
Analysts Offer Insights on Healthcare Companies: AMN Healthcare Services (AMN), Verona Pharma (VRNA) and Aveanna Healthcare Holdings (AVAH)
JMP Securities Maintains AMN Healthcare Services(AMN.US) With Buy Rating, Maintains Target Price $75
AMN Healthcare Services Analyst Ratings
Benchmark Co. Remains a Hold on AMN Healthcare Services (AMN)
AMN Healthcare Services Analyst Ratings
AMN Healthcare Services: Hold Rating With Positive Long-Term Outlook Amid Near-Term Pressures
Analysts Offer Insights on Healthcare Companies: Xeris Pharmaceuticals (XERS), AMN Healthcare Services (AMN) and 4D Molecular Therapeutics (FDMT)
AMN Healthcare Services Analyst Ratings
Buy Rating Affirmed for AMN Healthcare Services Amidst Cautious Optimism and Expected Turnaround
AMN Healthcare Services Analyst Ratings
Analysts Have Conflicting Sentiments on These Healthcare Companies: Petiq (PETQ), Leafly Holdings, Inc. (LFLY) and AMN Healthcare Services (AMN)
AMN Healthcare Services Receives Buy Rating Amid Strong Market Performance and Strategic Growth Initiatives
AMN Healthcare Services Analyst Ratings